Il Diabete最新文献

筛选
英文 中文
Possiamo ottenere un cambiamento dello stile di vita significativo e stabile nel tempo? 随着时间的推移,我们能实现有意义和稳定的生活方式改变吗?
Il Diabete Pub Date : 2023-05-18 DOI: 10.30682/ildia2301a
P. Moghetti
{"title":"Possiamo ottenere un cambiamento dello stile di vita significativo e stabile nel tempo?","authors":"P. Moghetti","doi":"10.30682/ildia2301a","DOIUrl":"https://doi.org/10.30682/ildia2301a","url":null,"abstract":"Lifestyle is universally considered a fundamental issue in the preven¬tion and therapy of both type 2 diabetes and metabolic syndrome. However, implementation at a general population level of recom¬mendations resulting from available evidence is largely insufficient. In particular, only a limited fraction of the general population meets the recommended levels of aerobic physical activity, and individuals meeting the recommended levels of resistance physical activity are even less. Interestingly, there is further reduction in these proportions in subjects with prediabetes and especially in those with type 2 diabe¬tes. It is noteworthy that people with or at risk for diabetes represent a significant proportion of the general population, show objective evi¬dence of impaired exercise capacity, for different mechanisms, and fre¬quently have long-standing sedentary habits, difficult to be changed. All these aspects should be taken into account, when designing in-tervention programs aimed at improving the current situation. As re¬gards the possibility of a stable increase in physical exercise levels and reduction in sedentary habits of individuals with diabetes, available data are limited. However, they indicate that it is possible to improve these aspects in a significant proportion of subjects. Behavioral chan¬ges reported in studies are generally smaller than the prefixed impro¬vements, but sufficient to obtain favorable and clinically significant effects. Interventions applied in these programs show several shortco¬mings, indicating the need for a continuous revision of strategies.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122015096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lo screening nella retinopatia diabetica 糖尿病视网膜病筛查
Il Diabete Pub Date : 2023-05-18 DOI: 10.30682/ildia2301f
Emanuele Fusi, Maria Vittoria Cicinelli, R. Lattanzio, F. Bandello
{"title":"Lo screening nella retinopatia diabetica","authors":"Emanuele Fusi, Maria Vittoria Cicinelli, R. Lattanzio, F. Bandello","doi":"10.30682/ildia2301f","DOIUrl":"https://doi.org/10.30682/ildia2301f","url":null,"abstract":"Diabetic retinopathy (DR) is the main ocular complication of diabetes. Among all the causes of blindness, it is the only one whose global pre-valence has increased over the past 30 years. DR prevalence is expected to increase in the upcoming years. Therefore, it is essential to establish cost-effective screening programs for early diagnosis of DR, which using new imaging systems, telemedicine and artificial intelligence prevent its evolution to advanced sight-threatening stages.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114228228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’esercizio fisico nel diabete di tipo 2: come possiamo migliorare l’aderenza? 糖尿病2型的运动:我们如何提高抓地力?
Il Diabete Pub Date : 2023-05-18 DOI: 10.30682/ildia2301c
A. Corrado, G. Annuzzi
{"title":"L’esercizio fisico nel diabete di tipo 2: come possiamo migliorare l’aderenza?","authors":"A. Corrado, G. Annuzzi","doi":"10.30682/ildia2301c","DOIUrl":"https://doi.org/10.30682/ildia2301c","url":null,"abstract":"\u0000Regular exercise is associated to several health benefits. However, only 39% of adults with type 2 diabetes reach the recommended goals for physical activity. Adherence to exercise needs removing barriers to behavioural changes by setting realistic goals. To make the chan¬ge lasting, group is fundamental and automatic behaviours must be created. However, the extent of the problem clearly indicates that a patient-centred approach is not enough. National policies including programs to encourage regular exercise are needed, with intensive in-terventions and investments. \u0000","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124037007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sindrome progeroide atipica con lipodistrofia parziale familiare, dovuta alla mutazione missenso c.1045 C > T (p.Arg349Trp) in eterozigosi del gene LMNA, e diabete mellito di tipo 2 由于c.1045突变引起的家族部分脂质营养不良的非典型原类综合症LMNA基因杂合子C > T (p.Arg349Trp)和2型糖尿病
Il Diabete Pub Date : 2023-05-18 DOI: 10.30682/ildia2301g
Benedetta Russo, I. Malandrucco, Marika Menduni, Andrea Mari, Caterina Pelosini, Francesco Brancati, Maria Rosaria D’Apice, Fabiana Picconi, S. Frontoni
{"title":"Sindrome progeroide atipica con lipodistrofia parziale familiare, dovuta alla mutazione missenso c.1045 C > T (p.Arg349Trp) in eterozigosi del gene LMNA, e diabete mellito di tipo 2","authors":"Benedetta Russo, I. Malandrucco, Marika Menduni, Andrea Mari, Caterina Pelosini, Francesco Brancati, Maria Rosaria D’Apice, Fabiana Picconi, S. Frontoni","doi":"10.30682/ildia2301g","DOIUrl":"https://doi.org/10.30682/ildia2301g","url":null,"abstract":"Familial partial lipodystrophy (FPLD) associated with LMNA gene mutations is a rare form of lipodystrophy disorder characterized by partial absence of subcutaneous adipose tissue and predisposition to develop metabolic complications related to insulin-resistance inclu-ding type 2 diabetes mellitus (T2D). Recently, this peculiar phenotype has been associated to atypical progeroid syndrome (APS). We present a case of 31-year-old woman with progeria features, partial lipodystro¬phy, type 2 diabetes mellitus (T2D), hypertriglyceridemia and hepatic steatosis. The baseline insulin sensitivity and secretion assessment showed strong insulin-resistance with hyperglycemia and elevated insulin secretion. Genetic analysis revealed a missense heterozygous LMNA mutation c.1045 C > T (p. Arg349Trp) that established APS diagnosis with FPLD, so far studied and described in only 10 patients worldwide. The patient was initially treated with metformin, fenofi¬brate, omega-3 and low carb and low fat diet with optimal results on metabolic control related to glycemic and lipid profile; later, liragluti¬de (Glucagon-Like Peptide-1 analog, GLP-1) therapy was added. Du¬ring the 6 month follow-up the anthropometric parameters improved, in particular a significant improvement in body composition with redi¬stribution of fat mass and a reduction of visceral fat and liver volume were observed. The improvements obtained were consolidated and maintained in the following years. However, with disease progression, focal segmental glomerulosclerosis (FSGS) and peripheral neuropathy developed. \u0000This case highlights the clinical and metabolic characteristics of this rare form of lipodystrophy and proposes an innovative therapeutic approach to manage the disease.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128152860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Il cambiamento che possiamo ottenere produce effetti clinicamente rilevanti? 我们所能得到的改变会产生重要的临床上的影响吗?
Il Diabete Pub Date : 2023-05-18 DOI: 10.30682/ildia2301b
G. Pugliese
{"title":"Il cambiamento che possiamo ottenere produce effetti clinicamente rilevanti?","authors":"G. Pugliese","doi":"10.30682/ildia2301b","DOIUrl":"https://doi.org/10.30682/ildia2301b","url":null,"abstract":"Adopting and maintaining a physically active lifestyle provides si¬gnificant health benefits to people with diabetes and prediabetes by increasing energy expenditure, insulin sensitivity, and physical fitness and decreasing chronic low-grade inflammation. Physical activity (PA)/exercise favors control of hyperglycemia and other risk factors for cardiovascular disease (CVD) and, therefore, it is recommended for diabetes prevention and treatment and for improving overall health. According to current guidelines, people with type 2 diabetes are re-commended to perform at least 150 min/week of moderate-to-vigorous intensity aerobic exercise plus 2-3 sessions/week of resistance exercise on non-consecutive days. Unfortunately, these individuals are usually well below the recommended level of PA and, hence, it is difficult for them to put into action guideline recommendations for a number of external and internal barriers, thus suggesting the need for effective strategies to promote a sustained behavior change. Several randomi¬zed clinical trials have shown that supervised exercise programs are effective in improving surrogate endpoints such as blood glucose and other CVD risk factors, physical fitness, and well-being. However, such programs are not suitable for long-term implementation in rou¬tine clinical practice and adherence to PA/exercise is usually strictly dependent on participation to supervised sessions and falls once the intervention ends. In this regard, counseling interventions appear to be more feasible and adequate to promote a true, long-lasting beha¬vior change. A limited number of studies have tested the efficacy of counseling interventions designed to promote walking through the provision of pedometers. These interventions resulted in modest and transient increases in moderate-to-vigorous PA (MVPA) and, accor¬dingly, failed to significantly improve CVD risk factors and other sur¬rogate outcomes or to produce sustained increases in cardiorespiratory fitness. These results are in contrast with those of several epidemio¬logical surveys, showing that, in physically inactive and sedentary or unfit individuals, even modest amounts of (MV)PA, corresponding to one-third to one-half of those recommended by guidelines, exert a beneficial impact on morbidity and mortality. This discrepancy might be explained by the fact that walking-based interventions are focused only on leisure-time MPVA. Conversely, current guidelines consider also other domains, such as sedentary behavior and light-intensity PA (LPA), and other settings, such as home, work and commuting, as they recommend also to decrease the amount of sedentary (SED)-time and to interrupt prolonged sitting with bouts of LPA every 30 min. In fact, in the Italian Diabetes and Exercise Study 2 (IDES_2), a counse¬ling intervention targeting both MVPA and sedentary behavior was effective in promoting increases in MVPA, which were modest but sustained over a three-year follow-up and associated wit","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"102 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134476540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meccanismi comuni tra diabete e declino cognitivo 糖尿病和认知衰退之间的常见机制
Il Diabete Pub Date : 2022-12-22 DOI: 10.30682/ildia2204a
Vittoria Cataldo, Lucia Scisciola, Martina Franzese, Armando Puocci, Michelangela Barbieri
{"title":"Meccanismi comuni tra diabete e declino cognitivo","authors":"Vittoria Cataldo, Lucia Scisciola, Martina Franzese, Armando Puocci, Michelangela Barbieri","doi":"10.30682/ildia2204a","DOIUrl":"https://doi.org/10.30682/ildia2204a","url":null,"abstract":"The increased prevalence of diabetes (DM) constitutes a major public health problem, primarily due to its numerous comorbidity and complications. It is widely demonstrated that DM is a significant risk factor for the development of cognitive impairment. Metabolic diseases can influence cognitive functions through multiple interconnected mechanisms. Cerebral insulin resistance, oxidative stress, neuroinflammation, and neuroendocrine dysfunctions can further the development of neurodegeneration diseases. The identification of the molecular mechanisms involved represents the target for the founding of early potential markers and new therapeutic targets of neurodegenerative diseases.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116978895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La terapia cellulare autologa è efficace nel trattamento delle ulcere del piede diabetico 自体细胞疗法在治疗糖尿病足溃疡方面非常有效
Il Diabete Pub Date : 2022-12-22 DOI: 10.30682/ildia2204e
{"title":"La terapia cellulare autologa è efficace nel trattamento delle ulcere del piede diabetico","authors":"","doi":"10.30682/ildia2204e","DOIUrl":"https://doi.org/10.30682/ildia2204e","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"150 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133812807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’elefante nella stanza 房间里的大象
Il Diabete Pub Date : 2022-12-22 DOI: 10.30682/ildia2204d
A. Piaggesi, Roberto Ferraresi, Mauro Gargiulo
{"title":"L’elefante nella stanza","authors":"A. Piaggesi, Roberto Ferraresi, Mauro Gargiulo","doi":"10.30682/ildia2204d","DOIUrl":"https://doi.org/10.30682/ildia2204d","url":null,"abstract":"Despite its increasing prevalence, severity and mortality, the Diabetic Foot Syndrome (DFS) still remains an unaddressed critical issue in Diabetology.\u0000The management of DFS is adequately performed only in few Centres, and clinical outcomes vary, depending on the possibility of patients to access optimal standards of care.\u0000To rivitalize the debate upond DFS and to make concrete proposals to improve the quality of therapy and the accessibility to optimal care, we wrote this editorial.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114425371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Il ripristino della funzione beta cellulare nel diabete mellito di tipo 2: aspetti traslazionali 2型糖尿病的细胞功能恢复:通病方面
Il Diabete Pub Date : 2022-12-22 DOI: 10.30682/ildia2204f
Mara Suleiman, Carmela De Luca, Silvia Del Guerra, Marta Tesi, L. Marselli
{"title":"Il ripristino della funzione beta cellulare nel diabete mellito di tipo 2: aspetti traslazionali","authors":"Mara Suleiman, Carmela De Luca, Silvia Del Guerra, Marta Tesi, L. Marselli","doi":"10.30682/ildia2204f","DOIUrl":"https://doi.org/10.30682/ildia2204f","url":null,"abstract":"Type 2 diabetes (T2D) has been considered a relentlessly worsening disease, due to the progressive deterioration of the pancreatic beta cell functional mass. Evidence indicates that remission of T2D may occur in variable proportions of patients after specific treatments that are associated with recovery of beta cell function. The recovery of beta cells has been shown in human islets obtained from non-diabetic organ donors that recover from “lipo-glucotoxic” conditions, and human islets isolated from T2D organ donors exposed to specific treatments or by a period of exposure to a “non-diabetic” milieu. The improvement of insulin secretion and the associated molecular traits unveil the possibility to promote T2D remission by directly targeting pancreatic beta cells.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128795331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crononutrizione: una tematica emergente nella gestione del diabete di tipo 2 营养:2型糖尿病管理的一个新主题
Il Diabete Pub Date : 2022-12-22 DOI: 10.30682/ildia2204c
Cristiana Randazzo, Carola Buscemi, Anna Maria Barile e Silvio Buscemi
{"title":"Crononutrizione: una tematica emergente nella gestione del diabete di tipo 2","authors":"Cristiana Randazzo, Carola Buscemi, Anna Maria Barile e Silvio Buscemi","doi":"10.30682/ildia2204c","DOIUrl":"https://doi.org/10.30682/ildia2204c","url":null,"abstract":"Evidence has been accumulated that a different timing in the consumption of meals, namely the chrononutrition, is able to influence the daily metabolic biorhythms, influencing the onset and possibly the treatment of clinical conditions as obesity and diabetes, including the possibility of independently influencing the cardiovascular risk. Behaviors originating from new social customs are able to interfere with these physiological mechanisms activating of genes and proteins that make individuals more or less flexible, capable of adaptation. So, the inability to adapt could favor a higher risk to health. Therefore, chrononutrition is a characteristic of the diet that is important to address further to the amount of energy and macronutrient intake. Once again, even in this area, the Mediterranean dietary style proves to be a healthy reference approach.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130494368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信